Learn how we simplify and accelerate the connection to care

Compliance Considerations for Direct-to-Patient Programs: What Pharma Needs in a Trusted Partner
Compliance Considerations for Direct-to-Patient Programs: What Pharma Needs in a Trusted Partner By Pouria Sanae, CEO, ixlayer As biopharma companies expand their use of direct-to-patient (DTP) programs, the compliance landscape